Study details
Enrolling now
EXPAND Trial
M.D. Anderson Cancer Center
NCT IDNCT06593431ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
80
Study length
about 4.7 years
Ages
18+
Locations
1 site in TX
What this study is about
This trial is testing whether consolidating radiation therapy improves progression-free survival and overall survival for people with small spots of pancreatic cancer that have spread to other parts of the body. It involves a randomized phase III trial.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Consolidative Radiation
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Safety and Adverse Events (AEs)
Procedures
radiation
Body systems
Oncology